23 May 2013
Keywords: novartis/gpc, sparc, trial, continues, after, interim, meeting
Article | 19 June 2006
Swiss drug major Novartis, German drugmaker GPC Biotech AG and the USA's Pharmion Corp say that the independent Data Monitoring ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 June 2006
© 2013 thepharmaletter.com